
CDx Diagnostics®: A pathology lab leveraging AI for cost-effective, early cancer detection.
cdxdiagnostics.comCrawled Oct 16, 2026
Esophageal cancer is often caught too late. CDx allows physicians to improve patient care with reliable early cancer screening and brush biopsy to preempt cancer.
Advanced imaging and AI-powered EndoCDx optimize Barrett’s detection with risk stratification, quantitative dysplasia assessment, and endoscopy analysis
The page provides resources on AI-powered 3D tissue analysis, including clinical studies and educational materials on early cancer detection and prevention.
CDx Diagnostics says its AI endoscopy enhances Barrett's detection, EGD accuracy, and automated mucosal assessment.
The WATS3D resource page includes clinical studies, case reports, and educational materials on AI-powered 3D tissue analysis for early cancer detection.
FDA granted Breakthrough Device Designation for its proprietary WATS3D diagnostic system for the diagnosis of Barrett’s esophagus and dysplasia.
New clinical data supporting the utility of the WATS3D test for BE and dysplasia has been selected for podium presentation at the 2025 DDW.
CDx Diagnostics advances cancer diagnostics with AI, 3D imaging, brush biopsy, Barrett’s surveillance, and precision medicine.
CDx Diagnostics enhances Barrett’s surveillance with AI-driven endoscopy, automated lesion detection, high-resolution EGD, and dysplasia detection software.
The page provides CDx Diagnostics bill pay information, insurance terms, and FAQs about patient billing.
WATS3D is included in guidelines for screening and surveillance of Barrett's esophagus.
CDx Diagnostics enhances Barrett’s detection with AI-driven EGD, deep learning, lesion mapping & dysplasia detection for early, precise cancer diagnostics
The page provides information about esophageal cancer and WATS3D’s role in screening and surveillance for patients with known or suspected Barrett’s esophagus.
CDx Diagnostics provides AI-enabled tissue analysis and 3D imaging for early detection of precancerous esophageal cells.
The notice describes how medical information may be used and disclosed and how individuals can access it.
CDx Diagnostics says it follows industry best practices to keep information secure.
The page explains the terms of service for the CDx website, including information about users’ legal rights, and states that using the site constitutes agreement to the terms.